Area of a triangle = 1/2 x base x height
a = 58.5
height = 9
58.5 = 1/2 x base x 9
58.5 = 4.5 x base
base = 13
Answer:
Here we have given two catogaries as degree holder and non degree holder.
So here we have to test the hypothesis that,
H0 : p1 = p2 Vs H1 : p1 not= p2
where p1 is population proportion of degree holder.
p2 is population proportion of non degree holder.
Assume alpha = level of significance = 5% = 0.05
The test is two tailed.
Here test statistic follows standard normal distribution.
The test statistic is,
Z = (p1^ - p2^) / SE
where SE = sqrt[(p^*q^)/n1 + (p^*q^)/n2]
p1^ = x1/n1
p2^ = x2/n2
p^ = (x1+x2) / (n1+n2)
This we can done in TI_83 calculator.
steps :
STAT --> TESTS --> 6:2-PropZTest --> ENTER --> Input all the values --> select alternative "not= P2" --> ENTER --> Calculate --> ENTER
Test statistic Z = 1.60
P-value = 0.1090
P-value > alpha
Fail to reject H0 or accept H0 at 5% level of significance.
Conclusion : There is not sufficient evidence to say that the percent of correct answers is significantly different between degree holders and non-degree holders.
Answer:
-48.9582
Step-by-step explanation:
Negative times a positive is negative.
In 1944 Elion joined the Burroughs Wellcome Laboratories (now part of GlaxoSmithKline (a company that makes prescription medicines)). There she was first the assistant and then the colleague of Hitchings, with whom she worked for the next four decades. Elion and Hitchings developed an array (variety) of new drugs that were effective against leukemia, autoimmune disorders, urinary-tract infections, gout, malaria, and viral herpes. Their success was due primarily to their innovative (characterized by new or unique) research methods. Rather than using the trial-and-error approach used by previous pharmacologists, Elion and Hitchings examined the difference between the biochemistry of normal human cells and that of cancer cells, bacteria, viruses, and other pathogens (disease-causing agents). They used this information to create drugs that could target a particular pathogen without harming the human host's normal cells. Their methods enabled them to eliminate much of the guesswork and wasted effort typical in previous drug research.
